¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"antigenic specificity"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • antigenic specificity
    Ç׿øÆ¯À̼º
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • diagnostic specificity
    Áø´ÜƯÀ̼º
  • ethnic specificity
    ÀÎÁ¾Æ¯À̼º
  • host specificity
    ¼÷ÁÖÆ¯À̼º
  • organ specificity
    ±â°üƯÀ̼º, Àå±âƯÀ̼º
  • species specificity
    Á¾Æ¯À̼º
  • specificity
    1. ƯÀ̼º 2. Ư¼ö¼º
  • strain specificity
    ÁÖÆ¯À̼º
  • antigenic deletion
    Ç׿ø°á¼Õ
  • antigenic determinant
    Ç׿ø°áÁ¤ÀÎÀÚ
  • antigenic diversion
    Ç׿øÀüȯ
  • antigenic drift
    Ç׿øº¯ÀÌ
  • antigenic profile
    Ç׿øÇÁ·ÎÇÊ
  • antigenic reversion
    Ç׿øº¹±Í
  • antigenic shift
    Ç׿øº¯À§
  • antigenic stimulation
    Ç׿øÀÚ±Ø
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • antigenic specificity
    Ç׿øÆ¯À̼º
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • antigenic determinant
    Ç׿ø°áÁ¤±â
  • antigenic stimulation
    Ç׿øÀÚ±Ø
  • specificity
    ƯÀ̼º
  • organ specificity
    ±â°üƯÀ̼º, Àå±âƯÀ̼º
  • species specificity
    Á¾Æ¯À̼º
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • antigenic specificity
    Ç׿øÆ¯À̼º
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • antigenic deletion
    Ç׿ø°á¼Õ
  • antigenic determinant
    Ç׿ø°áÁ¤±â
  • antigenic diversion
    Ç׿øÀüȯ
  • antigenic drift
    Ç׿ø¼ÒÆøº¯ÀÌ
  • antigenic profile
    Ç׿øÇÁ·ÎÇÊ
  • antigenic reversion
    Ç׿øº¹±Í
  • antigenic shift
    Ç׿øº¯À§
  • antigenic stimulation
    Ç׿øÀÚ±Ø
  • antigenic transformation
    Ç׿øº¯È¯
  • carrier specificity
    ³ª¸£°³Æ¯À̼º, ¸Å°³Æ¯À̼º, ¿î¹ÝüƯÀ̼º
  • compound specificity
    È­ÇÕ¹°Æ¯À̼º
  • diagnostic specificity
    Áø´ÜÀûƯÀ̼º
  • ethnic specificity
    ÀÎÁ¾ÀûƯÀ̼º
  • host specificity
    ¼÷ÁÖÆ¯À̼º
  • host-parasite specificity
    ¼÷ÁÖ±â»ýÃæÆ¯À̼º
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • antigenic specificity
    Ç׿øÆ¯À̼º(ù÷ê«÷åì¶àõ).
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • public specificity
    °øµ¿Æ¯À̼º
  • antigenic
    Ç׿ø¼º(¡­àõ)(ÀÇ).
  • antigenic
    Ç׿ø¼º(ÀÇ)
  • antigenic assay
    Ç׿ø¼ººÐ¼®
  • antigenic competition
    Ç׿ø°æÀï
  • antigenic deletion
    Ç׿ø°á½Ç(ù÷ê«ÌÀã÷).
  • antigenic determinant
    Ç׿ø°áÁ¤±â(¡­Ì½ïÒÐñ).
  • antigenic determinant
    Ç׿ø°áÁ¤±â(¡­Ì½ïÒÐñ).
  • antigenic determinant
    Ç׿ø°áÁ¤±â(¡­Ì½ïÒÐñ).
  • antigenic diversion
    Ç׿øÀüȯ(ù÷ê«ï®üµ).
  • antigenic drift
    Ç׿ø¼Òº¯ÀÌ
  • antigenic drift, influenza viruses
    Ç׿ø¼Òº¯ÀÌ(ù÷ê«á³Ü¨ì¶)
  • antigenic mimicry
    Ç׿øÀ¯»ç¼º
  • antigenic profile
    Ç׿ø(ù÷ê«)ÇÁ·ÎÇÊ.
  • antigenic reversion
    Ç׿øº¹±Í(ù÷ê«ÜÖÏý).
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • antigenic specificity
    Ç׿øÆ¯À̼º(ù÷ê«÷åì¶àõ).
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • carrier specificity
    ¿î¹ÝüƯÀ̼º
  • compound specificity
    È­ÇÕ¹°Æ¯À̼º(ûùùêÚª÷åì¶àõ).
  • diagnostic specificity
    Áø´ÜÀû ƯÀ̵µ
  • ethnic specificity
    ÀÎÁ¾(¹ÎÁ·)Àû ƯÀ̼º
  • organ specificity
    ±â°ü<Àå±â>ƯÀ̼º (¡­÷åì¶àõ).
  • organ specificity
    ±â°ü<Àå±â>ƯÀ̼º (Ðïί<íóÐï>÷åì¶àõ)
  • public specificity
    °øµ¿Æ¯À̼º
  • species specificity
    Á¾Æ¯À̼º(ðú÷åì¶àõ).
  • specificity
    ƯÁ¤¼º(÷åïÒàõ)
  • specificity
    ƯÀ̼º
  • specificness =specificity
    ƯÀ̵µ,ƯÀ̼º.
  • type specificity
    ÇüƯÀ̼º
  • antigenic
    Ç׿ø¼º(¡­àõ)(ÀÇ).
  • antigenic
    Ç׿ø¼º(ÀÇ)
  • antigenic assay
    Ç׿ø¼ººÐ¼®
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 4 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • host specificity
    ¼÷ÁÖÆ¯À̼º
  • host-parasite specificity
    ¼÷ÁÖ±â»ýÃæÆ¯À̼º
  • organ specificity
    ±â»ýÀå±âƯÀ̼º
  • species specificity
    Á¾Æ¯À̼º
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • antigenic competition
    Ç׿ø°æÇÕ(ù÷ê«Ìæùê)
  • antigenic conversion
    Ç׿øÀüȯ(ù÷ê«ï®üµ)
  • antigenic deletion
    Ç׿ø°á¼Õ(ù÷ê«ÌÀáß)
  • antigenic determinant
    Ç׿ø°áÁ¤¼Ò(ù÷ê«Ì½ïÒáÈ)
  • antigenic drift
    Ç׿ø¼º Ç¥·ù(ù÷ê«àõø÷×µ)
  • antigenic gain
    Ç׿ø¼º Áõ°¡(ù÷ê«àõñòÊ¥)
  • antigenic modulation
    Ç׿øÁ¶Á¤(ù÷ê«ðàïÚ)
  • absolute specificity
    Àý´ëƯÀ̼º (ï¾Óß÷åì¶àõ)
  • antibody specificity
    Ç×ü ƯÀ̼º(ù÷ô÷÷åì¶àõ)
  • base specificity
    ¿°±âƯÀ̼º(ç¤Ðñ÷åì¶àõ)
  • enzyme specificity
    È¿¼ÒƯÀ̼º(ý£áÈ÷åì¶àõ)
  • group specificity
    ±â(Ðñ) ƯÀ̼º(÷åì¶àõ)
  • sequece specificity
    ¼­¿­Æ¯À̼º(ßíÖª÷åì¶àõ)
  • specificity
    ƯÀ̼º(÷åì¶àõ)
  • specificity constant
    ƯÀ̼º »ó¼ö(÷åì¶àõßÈâ¦)
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • specificity
    ƯÀ̼º, ƯÀ̵µ
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 4 ÆäÀÌÁö: 1
SPEC specificity
MAD Major Antigenic Determinant
AD accident dispensary; acetate dialysis; active disease; acute dermatomyositis; addict, addiction; ade...
NAD neutrophil actin dysfunction; new antigenic determinant; nicotinamide adenine dinucleotide; nicotini...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
MAP Multiple Antigenic Peptide
VAT variant antigenic type
CPSF Cleavage and polyadenylation specificity factor
SP Specificity
SPEC specificity
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • antigenic specificity
    Ç׿ø ƯÀ̼º
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 4 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • antigenic assay
    Ç׿ø¼º ºÐ¼®
  • antigenic suicide
    Ç׿ø¿¡ ÀÇÇÑ ¸²ÇÁ±¸ÀÇ ÀÚ¸ê
    °íµµ·Î ¹æ»ç Ȱ¼ºÀÌ ÀÖ´Â Ç׿øÀ» »ýü¿¡ Åõ¿©Çϸé ÀÌ Ç׿ø¿¡ ´ëÇÏ¿© °¨¼ö¼ºÀÌ ÀÖ´Â ¸²ÇÁ±¸´Â °¨¼Ò ³»Áö ºÒȰ¼ºÈ­µÇ¾î ¹ö¸°´Ù. µû¶ó¼­ ¹æ»ç Ȱ¼ºÀÌ ¾ø´Â °°Àº Ç׿øÀ» Åõ¿©Çصµ ÀÌ Ç׿ø¿¡ ƯÀÌÀûÀÎ ¸é¿ª ÀÀ´äÀº »ý±âÁö ¾Ê°Ô µÈ´Ù. À̰ÍÀº Ç׿ø¿¡ ¹ÝÀÀÇÏ´Â ¸²ÇÁ±¸°¡ ¹æ»ç Ȱ¼ºÀÌ ÀÖ´Â Ç׿øÀ» °áÇÕ½ÃÅ´À¸·Î½á ¹æ»ç´É¿¡ ÀÇÇÑ ¼¼Æ÷ ¼Õ»óÀ» ÀԾ ¾ß±âµÇ´Â °ÍÀÌ´Ù. À̰ÍÀ» Ç׿ø¿¡ ÀÇÇÑ ¸²ÇÁ±¸ÀÇ ÀÚ¸êÀ̶ó°í ÇÑ´Ù.
  • carrier specificity
    ¿î¹Ýü ƯÀ̼º
  • compound specificity
    È­ÇÕ¹° ƯÀ̼º
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
antigenic Having the properties of an antigen (allergen).
Synonym: allergenic, immunogenic.
(05 Mar 2000)
antigenic competition Competition that occurs when two different antigens, each of which can evoke an immunological response when inoculated alone, are mixed in equal quantities and inoculated together; the response may be to only one, that to the other being largely or entirely suppressed.
(05 Mar 2000)
antigenic complex A composite of different antigenic structures, such as a cell or a bacterium, or, by extension, a molecule containing two or more determinant groups of different antigenic specificities.
(05 Mar 2000)
antigenic determinant That part of an antigenic molecule against which a particular immune response is directed. For instance a tetra to penta peptide sequence in a protein, a tri to penta glycoside sequence in a polysaccharide.
In the animal most antigens will present several or even many antigenic determinants simultaneously.
See: hapten.
(18 Nov 1997)
antigenic drift <immunology> A change that occurs on the molecular level to effect a change in the antigenicity of a bacteria or virus. Antigenic drift occurs naturally and more rapidly in certain viruses (for example HIV). It is antigenic drift which complicates the development of an effective HIV (AIDS) vaccine.
(27 Sep 1997)
antigenic modulation Loss of detectable antigen from the surface of a cell after incubation with antibodies. This is one method in which some tumours escape detection by the immune system. Antigenic modulation of target antigens also reduces the therapeutic effectiveness of treatment by monoclonal antibodies.
(12 Dec 1998)
antigenic shift Mutation, i.e., sudden change in molecular structure of RNA/DNA in microorganisms, especially viruses, which produces new strains of the microorganism; hosts previously exposed to other strains have little or no acquired immunity to the new strain; antigenic shift is believed to be the explanation for the occurrence of strains of microorganisms, such as the influenza virus, associated with large scale epidemics.
(05 Mar 2000)
antigenic switching <immunology> The process by which a pathogenic microbe's genetic structure is altered tochange its surface antigens inorder to avoid being detected by the host's immune system.
(09 Oct 1997)
antigenic variation The phenomenon of changes in surface antigens in parasitic populations of Trypanosoma and Plasmodium (and some other parasitic protozoa) in order to escape immunological defense mechanisms. at least 100 different surface proteins have been found to appear and disappear during antigenic variation in a clone of trypanosomes. Each antigen is encoded in a separate gene. Antigenic variation is also known to occur in free living Protozoa and certain bacteria.
(18 Nov 1997)
idiotypic antigenic determinant The antigenic specificites defined by the unique sequences (idiotopes) of the antigen combining site. Thus anti-idiotype antibodies combine with those specific sequences, may block immunological reactions and may resemble the epitope to which the first antibody reacts.
(18 Nov 1997)
analytical specificity Freedom from interference by any element or compound other than the analyte.
(05 Mar 2000)
antibody specificity The property of antibodies which enables them to react with some antigenic determinants and not with others. Specificity is dependent on chemical composition, physical forces, and molecular structure at the binding site.
(12 Dec 1998)
biological specificity <biology, zoology> The specific, orderly patterns of development and metabolism which define and characterise an individual and its species.
(21 Mar 1998)
relative specificity The specificity of a medical screening test as determined by comparison with the same type of test (e.g., specificity of a new serological test relative to specificity of an established serological test).
(05 Mar 2000)
sensitivity and specificity Measures for assessing the results of diagnostic and screening tests. Sensitivity represents the proportion of truly diseased persons in a screened population who are identified as being diseased by the test. It is a measure of the probability of correctly diagnosing a condition. Specificity is the proportion of truly nondiseased persons who are so identified by the screening test. It is a measure of the probability of correctly identifying a nondiseased person.
(12 Dec 1998)
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
antigenic specificity The property of mature B and T lymphocytes that enables them to respond to specific foreign antigens entering the body. Antigen specificity requires mature B and T cells that have been previously exposed to the antigen and,
Ãâó:
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • specificity
    Ư¼º;ƯÀ̼º;ÇÑÁ¤¼º
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á